# Collaborative H1N1 Adjuvant Treatment Pilot Trial

> **NCT01033955** · PHASE2 · TERMINATED · sponsor: **Canadian Critical Care Trials Group** · enrollment: 8 (actual)

## Conditions studied

- Critically Ill
- H1N1/Influenza Infection

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01033955
- **Lead sponsor:** Canadian Critical Care Trials Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** H1N1 pandemic concluded in early 2010
- **Last updated:** 2013-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033955, "Collaborative H1N1 Adjuvant Treatment Pilot Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01033955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
